GYRE THERAPEUTICS, INC. (GYRE)

Typically moves ±8.96% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-10 ESTIMATED

GYRE THERAPEUTICS, INC. (GYRE) has a 17-report earnings history dating back to May 06, 2021. Its average absolute post-earnings move is ±8.96%, and 47.1% of those reactions were positive. Its largest post-earnings gain was +13.64% (May 09, 2025) and its largest decline was -41.84% (Nov 12, 2021). The next earnings report is predicted for 2026-11-10 (estimated).

Earnings reactions

How GYRE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.96%

Positive %

47.1%

Negative %

52.9%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 07, 2026	☀ PRE	+2.78%	open_in_new
May 07, 2026	☽ POST	+4.6%	open_in_new
Mar 12, 2026	☽ POST	-3.2%	open_in_new
Nov 07, 2025	☽ POST	+9.85%	open_in_new
Aug 11, 2025	☽ POST	+6.93%	open_in_new
May 09, 2025	☽ POST	+13.64%	open_in_new
Mar 17, 2025	☽ POST	-30.21%	open_in_new
Nov 13, 2024	☽ POST	-4.42%	open_in_new
Aug 13, 2024	☽ POST	-4.04%	open_in_new
May 09, 2024	☽ POST	-2.69%	open_in_new
Mar 26, 2024	☽ POST	+4.41%	open_in_new
Aug 14, 2023	☀ PRE	+2.94%	open_in_new
Aug 15, 2022	☽ POST	-2.07%	open_in_new
May 09, 2022	☽ POST	-15.91%	open_in_new
Nov 12, 2021	☀ PRE	-41.84%	open_in_new
Aug 05, 2021	☀ PRE	+0.49%	open_in_new
May 06, 2021	☀ PRE	-2.37%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.96%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 13 →

Funds holding

$11070038

Total value held

Buying

13 added · 0 reduced

Blackrock, Inc.

$6550085 +31.02%

State Street Corp

$1617199 +13.44%

Northern Trust Corp

$1117249 +26.67%

Goldman Sachs Group Inc

$568289 +17.93%

Bank Of New York Mellon Corp

$413523 +45.44%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260901	open_in_new SEC.gov
S-8	20260831	open_in_new SEC.gov
8-K	20260826	open_in_new SEC.gov
10-Q	20260807	open_in_new SEC.gov
8-K	20260807	open_in_new SEC.gov
3	20260804	open_in_new SEC.gov
3	20260804	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov
EFFECT	20260803	open_in_new SEC.gov

Frequently asked about GYRE earnings

When does GYRE THERAPEUTICS, INC. report earnings next? expand_more

GYRE THERAPEUTICS, INC. (GYRE)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GYRE stock move after earnings? expand_more

Over 17 reports, GYRE has moved an average of ±8.96% the session after earnings, closing higher 47.1% of the time.

What was GYRE's biggest post-earnings move? expand_more

GYRE's largest post-earnings gain on record was +13.64% on May 09, 2025, and its largest decline was -41.84% on Nov 12, 2021.

Where can I find GYRE THERAPEUTICS, INC.'s SEC filings? expand_more

All of GYRE THERAPEUTICS, INC.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.